Pregnancy planning does not interfere with child development in children aged from 11 to 23 months old

Katherine Solís-Cordero1, Luciana Assis Couto1,2, Luciane Simões Duarte3

  • 1Universidade de São Paulo, Escola de Enfermagem, São Paulo, SP, Brazil.

Insights

Pregnancy planning did not correlate with child development in a study of 125 dyads. However, socioeconomic factors like Bolsa Família and child

Area of Science:

  • Pediatrics
  • Public Health
  • Developmental Psychology

Background:

  • Pregnancy planning is crucial for maternal and child well-being.
  • Socioeconomic factors can significantly impact child development outcomes.
  • Understanding the interplay between planning and development is vital for targeted interventions.

Purpose of the Study:

  • To investigate the correlation between child development and pregnancy planning.
  • To explore other factors associated with child development in disadvantaged areas.

Main Methods:

  • Cross-sectional study of 125 mother-child dyads (children aged 11-23 months).
  • Child development assessed using Ages & Stages Questionnaire-BR.
  • Pregnancy planning evaluated with the London Measure of Unplanned Pregnancy.

Main Results:

  • 17.6% unplanned, 24.8% planned, 57.6% ambivalent pregnancies.
  • Inadequate child development (21%-40%) was not linked to pregnancy planning.
  • Developmental domains associated with Bolsa Família, child's gender, and age.

Conclusions:

  • No direct correlation found between pregnancy planning and child development.
  • High rates of inadequate development and low planned pregnancies highlight a need for improved preconception and contraceptive care.
  • Investment in health professional training is recommended for socioeconomically disadvantaged contexts.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
29
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
954
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Planning Nursing Care I01:21

Planning Nursing Care I

The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
5.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22